310 related articles for article (PubMed ID: 32825964)
1. Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinical outcomes.
Dias Lopes NM; Mendonça Lens HH; Armani A; Marinello PC; Cecchini AL
Pathol Res Pract; 2020 Sep; 216(9):153098. PubMed ID: 32825964
[TBL] [Abstract][Full Text] [Related]
2. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
3. Hashimoto's Thyroiditis and Graves' Disease in Genetic Syndromes in Pediatric Age.
Casto C; Pepe G; Li Pomi A; Corica D; Aversa T; Wasniewska M
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33557156
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of IKZF3 Gene and Autoimmune Thyroid Diseases: Associated with Graves' Disease but Not with Hashimoto's Thyroiditis.
Li L; Ding X; Wang X; Yao Q; Shao X; An X; Yan N; Jiang Y; Wang W; Shi L; Qin Q; Song R; Zhang JA; Sun P
Cell Physiol Biochem; 2018; 45(5):1787-1796. PubMed ID: 29510406
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of thyroid autoimmune diseases: New T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm.
Li Q; Wang B; Mu K; Zhang JA
J Cell Physiol; 2019 Mar; 234(3):2204-2216. PubMed ID: 30246383
[TBL] [Abstract][Full Text] [Related]
6. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients.
Wiebolt J; Achterbergh R; den Boer A; van der Leij S; Marsch E; Suelmann B; de Vries R; van Haeften TW
Eur J Endocrinol; 2011 May; 164(5):789-94. PubMed ID: 21378091
[TBL] [Abstract][Full Text] [Related]
7. Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study.
He W; Zhao J; Liu X; Li S; Mu K; Zhang J; Zhang JA
BMC Endocr Disord; 2021 Jul; 21(1):148. PubMed ID: 34238277
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Expression of Different Histone Deacetylases in Autoimmune Thyroid Disease.
Sacristán-Gómez P; Serrano-Somavilla A; González-Amaro R; Martínez-Hernández R; Marazuela M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3213-3227. PubMed ID: 34272941
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the association studies of autoimmune thyroid disease and the functional characterization of AITD-related transcription factor ZFAT.
Nakabayashi K; Shirasawa S
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):66-72. PubMed ID: 20453441
[TBL] [Abstract][Full Text] [Related]
10. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.
Ganesh BB; Bhattacharya P; Gopisetty A; Prabhakar BS
J Interferon Cytokine Res; 2011 Oct; 31(10):721-31. PubMed ID: 21823922
[TBL] [Abstract][Full Text] [Related]
11. Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer.
Imam S; Dar P; Paparodis R; Almotah K; Al-Khudhair A; Hasan SA; Salim N; Jaume JC
J Immunother Cancer; 2019 Jan; 7(1):3. PubMed ID: 30616690
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility genes in thyroid autoimmunity.
Ban Y; Tomer Y
Clin Dev Immunol; 2005 Mar; 12(1):47-58. PubMed ID: 15712599
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of IL37 gene as a protective factor for autoimmune thyroid disease.
Yan N; Meng S; Song RH; Qin Q; Wang X; Yao Q; Jiang Y; Jiang W; Shi L; Xu J; Zhang J
J Mol Endocrinol; 2015 Dec; 55(3):209-18. PubMed ID: 26373794
[TBL] [Abstract][Full Text] [Related]
14. Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease.
Tagoe CE; Zezon A; Khattri S
J Rheumatol; 2012 Jun; 39(6):1125-9. PubMed ID: 22505695
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Thyroid Disorders and Inflammatory Bowel Disease: A Literature Review.
Shizuma T
Biomed Res Int; 2016; 2016():5187061. PubMed ID: 27042663
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms.
Ramos-Leví AM; Marazuela M
Endocrinol Nutr; 2016 Oct; 63(8):421-9. PubMed ID: 27234136
[TBL] [Abstract][Full Text] [Related]
17. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 polymorphisms (+49 A/G and -318 C/T) are important genetic determinants of AITD susceptibility and predisposition to high levels of thyroid autoantibodies in Polish children - preliminary study.
Pastuszak-Lewandoska D; Domańska D; Rudzińska M; Bossowski A; Kucharska A; Sewerynek E; Czarnecka K; Migdalska-Sęk M; Czarnocka B
Acta Biochim Pol; 2013; 60(4):641-6. PubMed ID: 24364045
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders.
Vitales-Noyola M; Ramos-Levi AM; Martínez-Hernández R; Serrano-Somavilla A; Sampedro-Nuñez M; González-Amaro R; Marazuela M
Endocrine; 2017 Sep; 57(3):409-417. PubMed ID: 28669056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
